Role of TGF-s in normal human endometrium and endometriosis

Human Reproduction

Volumn 25, Issue 1, 2010, Pages 101-109

  Omwandho, Charles O A ^a   Konrad, Lutz ^b   Halis, Gülden ^c   Oehmke, Frank ^b   Tinneberg, Hans Rudolf ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b Department of Gynecology and Obstetrics ^*  (Germany)

^c Fertility and Endometriosis Center   (Germany)

Author keywords

Diagnosis; Endometriosis; Menstruation; TGF beta

Indexed keywords

BIOLOGICAL MARKER; CONTRACEPTIVE AGENT; ESTRADIOL; MESSENGER RNA; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA; ESTROGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; BLEEDING; CELL ADHESION; CELL INVASION; CELL SURVIVAL; CLINICAL FEATURE; ENDOMETRIOSIS; ENDOMETRIUM; ESCAPE BEHAVIOR; GENETIC PREDISPOSITION; HORMONAL REGULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INFERTILITY; MACROPHAGE; MENSTRUATION; METASTASIS; NONHUMAN; PAIN; PERITONEAL CAVITY; PERITONEUM; PREIMPLANTATION EMBRYO; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGENERATION; REVIEW; STROMA; UTERUS FLUID; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BIOLOGICAL MARKERS; ENDOMETRIOSIS; ENDOMETRIUM; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENSTRUATION; PROGESTERONE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 72849106053     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep382     Document Type: Review

References (105)

1. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43:97-110.
2. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006;62:139-147.
3. Agic A, Djalali S, Wolfler MM, Halis G, Diedrich K, Hornung D. Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci 2008;15:906-911.
4. Arandjelovic S, Van Sant CL, Gonias SL. Limited mutations in full-length tetrameric human alpha2-macroglobulin abrogate binding of platelet-derived growth factor-BB and transforming growth factor-beta1. J Biol Chem 2006;281:17061-17068.
5. Arici A, MacDonald PC, Casey M. Modulation of the levels of transforming growth factor b messenger ribonucleic acids in human endometrial stromal cells. Biol Reprod 1996;54:463-469. (Pubitemid 26031417)
6. Balasch J, Creus M, Fabregues F, Carmona F, Ordi J, Martinez-Roman S, Vanrell JA. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996;11:387-391.
7. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta 2004;340:41-56.
8. Beliard A, Noel A, Goffin F, Frankenne F, Foidart JM. Adhesion of endometrial cells labeled with 111Indium-tropolonate to peritoneum: a novel in vitro model to study endometriosis. Fertil Steril 2003; 79(Suppl. 1):724-729.
9. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG. Transforming growth factor-b mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995;92:7362-7366.
10. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG. Steroid regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002;87:4782-4791.
11. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG. Down-regulation of endometrial matrix metalloproteinase-3 and-7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J Clin Endocrinol Metab 2006;91:1554-1560.
12. Buchweitz O, Staebler A, Tio J, Kiesel L. Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy. Am J Obstet Gynecol 2006;195:949-954.
13. Bulletti C, De Ziegler D, Polli V, Del Ferro E, Palini S, Flamigni C. Characteristics of uterine contractility during menses in women with mild to moderate endometriosis. Fertil Steril 2002;77:1156-1161.
14. Bulletti C, De Ziegler D, Setti PL, Cicinelli E, Polli V, Flamigni C. The patterns of uterine contractility in normal menstruating women: from physiology to pathology. Ann N Y Acad Sci 2004;1034:64-83.
15. Candiani GB, Fedele L, Vercellini P, Bianchi S, DiNola G. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol 1991;77:421-424.
16. Casslen B, Sandberg T, Gustavsson B, Willen R, Nilbert M. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol Reprod 1998;58:1343-1350.
17. Chegini N. TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation. Semin Reprod Med 2008;26:298-312.
18. 125I]TGFb1-binding sites. Endocrinology 1994;135:439-449.
19. Cherlet T, Murphy LC. Estrogen receptors inhibit Smad3 transcriptional activity through AP-1 transcription factors. Mol Cell Biochem 2007; 306:33-42.
20. Cornet PB, Picquet C, Lemoine P, Osteen KG, Bruner-Tran KL, Tabibzadeh S, Courtoy PJ, Eeckhout Y, Marbaix E, Henriet P. Regulation and function of LEFTY-A/EBAF in the human endometrium. J Biol Chem 2002;277:42496-42504.
21. Cramer DW. Endometriosis. Epidemiology of Endometriosis in Adolescents. Alan Liss, 1987, 5-8.
22. Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 2005;41:846-857.
23. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584.
24. Derynck R, Akhurst RJ, Balmain A. TGF-b signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-129.
25. D'Hooghe TM, Xiao L, Hill JA. Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet 2001;265:40-44.
26. Eriksson M, Meadows SK, Wira CR, Sentman CL. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-b. J Leukoc Biol 2004;76:667-675.
27. Eriksson M, Meadows SK, Wira CR, Sentman CL. Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol 2006;56:321-328.
28. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-258.
29. Evers JL, Dunselman GA, Groothuis P. Now you see them, now you don't. Fertil Steril 2005;84:31-32; dscussion 38-39.
30. Gaide Chevronnay HP, Cornet PB, Delvaux D, Lemoine P, Courtoy PJ, Henriet P, Marbaix E. Opposite regulation of transforming growth factor-b2 and-b3 expression in the human endometrium. Endocrinology 2008;149:1015-1025.
31. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1997;5:642-650.
32. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
33. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, Korc M, Demopoulos RI. Increased expression of transforming growth factor b isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994;54:2347-2358.
34. Grainger DJ, Mosedale DE, Metcalfe JC. TGF-b in blood: a complex problem. Cytokine Growth Factor Rev 2000;11:133-154.
35. Hadfield RM, Mardon HJ, Barlow DH, Kennedy SH. Endometriosis in monozygotic twins. Fertil Steril 1997;68:941-942.
36. Hao M, Shi Y, Dong M. Measurements of interleukin-6, interleukin-8 and transforming growth factor-beta1 levels in peritoneal fluid of patients with endometriosis. Zhonhua Fu Chan Ke Za Zhi 2000;35:329-331.
37. Hayrabedyan S, Kyurkchiev S, Kehayov I. FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. J Reprod Immunol 2005; 67:87-101.
38. Houston DE. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 1984;6:167-191.
39. Husby GK, Haugen RS, Moen MH. Diagnostic delay in women with pain and endometriosis. Acta Obstet Gynecol Scand 2003;82:649-653.
40. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
41. Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006;25:435-457.
42. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 2008;40:1068-1978.
43. Johnson MC, Torres M, Alves A, Bacallao K, Fuentes A, Vega M, Boric MA. Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes. Reprod Biol Endocrinol 2005;3:45.
44. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-ß superfamily expression and actions in the endometrium and placenta. Reproduction 2006;132:217-232.
45. Kanzaki H, Hatayama H, Narukawa S, Kariya M, Fujita J, Mori T. Hormonal regulation in the production of macrophage colony-stimulating factor and transforming growth factor-beta by human endometrial stromal cells in culture. Horm Res 1995;44(Suppl. 2):30-35.
46. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995;12:32-34.
47. Kim SH, Choi YM, Chae HD, Kim KR, Kim CH, Kang BM. Increased expression of endoglin in the eutopic endometrium of women with endometriosis. Fertil Steril 2001;76:918-922.
48. Kimatrai M, Oliver C, Abadia-Molina AC, Garcia-Pacheco JM, Olivares EG. Contractile activity of human decidual stromal cells. J Clin Endocrinol Metab 2003;88:844-849.
49. Koks CA, Dunselman GA, de Goeij AF, Arends JW, Evers JL. Evaluation of a menstrual cup to collect shed endometrium for in vitro studies. Fertil Steril 1997;68:560-564.
50. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J. Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 2001; 52:354-362.
51. Komiyama S, Aoki D, Komiyama M, Nozawa S. Local activation of TGF-beta1 at endometriosis sites. J Reprod Med 2007;52:306-312.
52. Kothapalli R, Buyuksal I, Wu SQ, Chegini N, Tabibzadeh S. Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily association of gene expression with endometrial bleeding. J Clin Invest 1997;99:2342-2350.
53. Kuohung W, Jones GL, Vitonis AF, Cramer DW, Kennedy SH, Thomas D, Hornstein MD. Characteristics of patients with endometriosis in the United States and the United Kingdom. Fertil Steril 2002;78:767-772.
54. Küpker W, Schultze-Mosgau A, Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis. Human Reprod Update 1998;4:719-723.
55. Lea RG, Clark DA. Macrophages and migratory cells in endometrium relevant to implantation. Baillieres Clin Obstet Gynaecol 1991;5:25-59.
56. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000;73:1089-1096.
57. Liu DT, Hitchcock A. Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol 1986;93:859-862.
58. Liu YG, Tekmal RR, Binkley PA, Nair HB, Schenken RS, Kirma NB. Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta. Mol Hum Reprod 2009;15:665-673.
59. Luo X, Xu J, Chegini N. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-b. J Clin Endocrinol Metab 2003a; 88:4967-4976.
60. Luo X, Xu J, Chegini N. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Reprod Biol Endocrinol 2003b; 1:125.
61. Lutz M, Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 2002;14:977-988.
62. Machino GL, Gennarelli GL, Enria R, Bongioanni F, Lipari G, Massobrio M. Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertil Steril 2005;84:12-15.
63. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003;9:223-228.
64. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-ß and estrogen receptor signalling through Smad3. J Biol Chem 2001;276:42908-42914.
65. Memon MA, Anway MD, Covert TR, Uzumcu M, Skinner MK. Transforming growth factor beta (TGF-beta1, TGF-beta2 and TGF-beta3) null-mutant phenotypes in embryonic gonadal development. Mol Cell Endocrinol 2008;294:70-80.
66. Meresman GF, Bilotas M, Buquet RA, Baranao RI, Sueldo C, Tesone M. Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis. Fertil Steril 2003;80(Suppl. 2):702-707.
67. Murphy AA, Guzick DS, Rock JA. Microscopic peritoneal endometriosis. Fertil Steril 1989;51:1072-1074.
68. Namnoum AB, Hickman TN, Gooman SB, Gehlbach DL, Rock JA. Incidence of symptoms recurrence after hysterectomy for endometriosis. Fertil Steril 1995;64:898-902.
69. Nasu K, Nishida M, Matsumoto H, Bing S, Inoue C, Kawano Y, Miyakawa I. Regulation of proliferation, motility and contractivity of cultured human endometrial stromal cells by transforming growth factor-beta isoforms. Fertil Steril 2005;84(Suppl. 2):1114-1123. (Pubitemid 41396536)
70. Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C. The relationship of endometriosis and ovarian malignancy. Fertil Steril 2008; 90:1559-1570.
71. Nisolle M, Paindaveine B, Bourdon A, Berliere M, Casanas-Roux F, Donnez J. Histologic study of peritoneal endometriosis in infertile women. Fertil Steril 1990;53:984-988.
72. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR. Transforming growth factor-b activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994;83:287-292.
73. Osteen KG, Keller NR, Feltus FA, Melner MH. Paracrine regulation of matrix metalloproteinase expression on the normal human endometrium. Gynecol Obstet Invest 1999;48(Suppl. 1):2-13.
74. Osteen KG, Igarashi TM, Bruner-Tran KL. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression. Front Biosci 2003; 8:d78-d86.
75. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastastic factor in human cancer. Biochim Biophys Acta 2007; 1775:21-62.
76. Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecol Endocrinol 2006;22:698-703.
77. Pizzo A, Salmeri FM, Ardita FV, Sofo V, Tripepi M, Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 2002;54:82-87.
78. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril 2006;86(Suppl. 5):S156-S160.
79. Rahimi RA, Leof BE. TGF-b signaling: a tale of two responses. J Cell Biochem 2007;102:593-608.
80. Ruddock NK, Shi SQ, Jain S, Moore G, Hankins GD, Romero R, Garfield RE. Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 2008;391:e1-e7.
81. Salamonsen LA, Marsh MM, Findlay JK. Endometrial endothelin: regulator of uterine bleeding and endometrial repair. Clin Exp Pharmacol Physiol 1999;26:154-157.
82. Samuels P, Tan AK. Fetal scarless wound healing. J Otolaryngol 1999; 28:296-302.
83. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J, Barnhart KT. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 2008;89:1073-1081.
84. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.
85. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D et al. Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
86. Simpson JL, Elias S, Malinak LR, Buttram VC Jr. Heritable aspects of endometriosis I: genetic studies. Am J Obstet Gynecol 1980;137: 327-331.
87. Snesky TE, Liu DT. Endometriosis: association with menorrhagia, infertility and oral contraceptives. Int J Gynaecol Obstet 1980;17:573-576.
88. Starzinski-Powitz A, Handrow-Metzacher H, Kotzian S. The putative role of cell adhesion molecules in endometriosis: can we learn from tumour metastasis? Mol Med Today 1999;5:304-309.
89. Stefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, Ingadottir G, Gulcher J, Stefansson K. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002; 17:555-559.
90. Tabibzadeh S. Homeostasis of extracellular matrix by TGF-beta and lefty. Front Biosci 2002;7:d1231-d1246.
91. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 2000; 85:2526-2536.
92. Tamburro S, Canis M, Albuisson E, Dechelotte P, Darcha C, Mage G. Expression of transforming growth factor b1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril 2003;80:1131-1136.
93. Tamura M, Fukaya T, Enomoto A, Murakami T, Uehara S, Yajima A. Transforming growth factor-beta isoforms and receptors in endometriotic cysts of the human ovary. Am J Reprod Immunol 1999;42:160-167.
94. Tang XM, Zhao Y, Rossi MJ, Abu-Rustum RS, Ksander GA, Chegini N. Expression of transforming growth factor-b (TGFb) isoforms and TGFb type II receptor messenger ribonucleic acid and protein, and the effect of TGFbs on endometrial stromal cell growth and protein degradation in vitro. Endocrinology 1994;135:450-459.
95. Tang M, Taylor HS, Tabibzadeh S. In vivo gene transfer of lefty leads to implantation failure in mice. Hum Reprod 2005;20:1772-1778.
96. Tempfer CB, Simoni M, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part II-endometriosis. Hum Reprod Update 2009;15:97-118.
97. Ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008;11:79-89.
98. Ulloa L, Tabibzadeh S. Lefty inhibits receptor-regulated Smad phosphorylation induced by the transforming growth factor-beta receptor. J Biol Chem 2001;276:21397-21404.
99. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann NY Acad Sci 2003;997:229-239.
100. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor b1-an intimate relationship. Eur J Cell Biol 2008;87:601-615.
101. Yanez RA, Gonzalez MM. Endometriosis: physiopathology and investigation trends (first part). Gynecol Obstet Mex 2007;75:477-483.
102. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen receptor element activated by metabolites of 17b-estradiol and raloxifene. Science 1996;273:1222-1225; correction in Science 275,1249.
103. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, Sung J, Xiong X, Munger JS. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGF-beta1-null mice. J Cell Biol 2007;176:787-793.
104. Zhang EG, Smith Sk, Charnock-Jones DS. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle. Reproduction 2002;124:703-711.
105. Zhou HE, Nothnick WB. The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis. Front Biosci 2005; 10:569-575.